158 related articles for article (PubMed ID: 16373426)
1. Naturally arising CD4+CD25+ regulatory T cells suppress the expansion of colitogenic CD4+CD44highCD62L- effector memory T cells.
Kanai T; Tanimoto K; Nemoto Y; Fujii R; Makita S; Totsuka T; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G1051-8. PubMed ID: 16373426
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M
Gastroenterology; 2007 Jan; 132(1):176-89. PubMed ID: 17241870
[TBL] [Abstract][Full Text] [Related]
3. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
[TBL] [Abstract][Full Text] [Related]
4. Upregulated IL-7 receptor α expression on colitogenic memory CD4+ T cells may participate in the development and persistence of chronic colitis.
Shinohara T; Nemoto Y; Kanai T; Kameyama K; Okamoto R; Tsuchiya K; Nakamura T; Totsuka T; Ikuta K; Watanabe M
J Immunol; 2011 Feb; 186(4):2623-32. PubMed ID: 21217010
[TBL] [Abstract][Full Text] [Related]
5. RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
Totsuka T; Kanai T; Nemoto Y; Tomita T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Akiba H; Okumura K; Yagita H; Watanabe M
J Immunol; 2009 May; 182(10):6079-87. PubMed ID: 19414759
[TBL] [Abstract][Full Text] [Related]
6. Long-lived colitogenic CD4+ memory T cells residing outside the intestine participate in the perpetuation of chronic colitis.
Nemoto Y; Kanai T; Kameyama K; Shinohara T; Sakamoto N; Totsuka T; Okamoto R; Tsuchiya K; Nakamura T; Sudo T; Matsumoto S; Watanabe M
J Immunol; 2009 Oct; 183(8):5059-68. PubMed ID: 19786550
[TBL] [Abstract][Full Text] [Related]
7. FTY720 suppresses CD4+CD44highCD62L- effector memory T cell-mediated colitis.
Fujii R; Kanai T; Nemoto Y; Makita S; Oshima S; Okamoto R; Tsuchiya K; Totsuka T; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G267-74. PubMed ID: 16574986
[TBL] [Abstract][Full Text] [Related]
8. IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice.
Takahara M; Nemoto Y; Oshima S; Matsuzawa Y; Kanai T; Okamoto R; Tsuchiya K; Nakamura T; Yamamoto K; Watanabe M
Immunol Lett; 2013; 156(1-2):82-93. PubMed ID: 24070768
[TBL] [Abstract][Full Text] [Related]
9. Continuous generation of colitogenic CD4(+) T cells in persistent colitis.
Tomita T; Kanai T; Fujii T; Nemoto Y; Okamoto R; Tsuchiya K; Totsuka T; Sakamoto N; Watanabe M
Eur J Immunol; 2008 May; 38(5):1264-74. PubMed ID: 18412157
[TBL] [Abstract][Full Text] [Related]
10. IL-7 is essential for lymphopenia-driven turnover of colitogenic CD4(+) memory T cells in chronic colitis.
Tomita T; Kanai T; Totsuka T; Nemoto Y; Okamoto R; Tsuchiya K; Sakamoto N; Ohteki T; Hibi T; Watanabe M
Eur J Immunol; 2009 Oct; 39(10):2737-47. PubMed ID: 19637223
[TBL] [Abstract][Full Text] [Related]
11. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
12. IL-2 is positively involved in the development of colitogenic CD4+ IL-7R alpha high memory T cells in chronic colitis.
Kameyama K; Nemoto Y; Kanai T; Shinohara T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Totsuka T; Hibi T; Watanabe M
Eur J Immunol; 2010 Sep; 40(9):2423-36. PubMed ID: 20623548
[TBL] [Abstract][Full Text] [Related]
13. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.
Fantini MC; Rizzo A; Fina D; Caruso R; Sarra M; Stolfi C; Becker C; Macdonald TT; Pallone F; Neurath MF; Monteleone G
Gastroenterology; 2009 Apr; 136(4):1308-16, e1-3. PubMed ID: 19192480
[TBL] [Abstract][Full Text] [Related]
14. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
15. Regulation of murine chronic colitis by CD4+CD25- programmed death-1+ T cells.
Totsuka T; Kanai T; Makita S; Fujii R; Nemoto Y; Oshima S; Okamoto R; Koyanagi A; Akiba H; Okumura K; Yagita H; Watanabe M
Eur J Immunol; 2005 Jun; 35(6):1773-85. PubMed ID: 15902682
[TBL] [Abstract][Full Text] [Related]
16. The development of colitogenic CD4(+) T cells is regulated by IL-7 in collaboration with NK cell function in a murine model of colitis.
Yamaji O; Nagaishi T; Totsuka T; Onizawa M; Suzuki M; Tsuge N; Hasegawa A; Okamoto R; Tsuchiya K; Nakamura T; Arase H; Kanai T; Watanabe M
J Immunol; 2012 Mar; 188(6):2524-36. PubMed ID: 22331065
[TBL] [Abstract][Full Text] [Related]
17. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
18. Competition between colitogenic Th1 and Th17 cells contributes to the amelioration of colitis.
Mikami Y; Kanai T; Sujino T; Ono Y; Hayashi A; Okazawa A; Kamada N; Matsuoka K; Hisamatsu T; Okamoto S; Takaishi H; Inoue N; Ogata H; Hibi T
Eur J Immunol; 2010 Sep; 40(9):2409-22. PubMed ID: 20706984
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
